Ross Stores (ROST) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Jan, 2026Executive summary
Q3 2024 sales rose to $5.1 billion, up 3% year-over-year, with comparable store sales up 1% and net income increasing to $489 million.
EPS for Q3 was $1.48, up from $1.33 last year; nine-month EPS was $4.53 on net income of $1.5 billion.
Sales growth slowed in Q3 due to weather and merchandising execution issues, impacting discretionary spending.
89 new stores opened year-to-date, bringing the total to 2,192 locations.
CEO transition announced: James G. Conroy to become CEO in February 2025, with Barbara Rentler moving to an advisory role.
Financial highlights
Operating margin for Q3 improved to 11.9% from 11.2% year-over-year; gross margin rose as cost of goods sold fell to 71.7% of sales.
SG&A expenses as a percentage of sales decreased to 16.4% from 16.5% year-over-year.
Net cash provided by operating activities for nine months was $1.47 billion.
$787.5 million spent on share repurchases and $367.5 million paid in dividends year-to-date.
Strongest merchandise areas in Q3 were cosmetics, accessories, and children; best-performing regions were California and Texas.
Outlook and guidance
Q4 comparable store sales projected to increase 2%-3%; EPS guidance for Q4 is $1.57-$1.64, down from $1.82 last year due to packaway expense timing.
Full-year EPS expected in the range of $6.10-$6.17, up from $5.56 last year, noting last year included an extra week that benefited EPS by $0.20.
Operating margin for Q4 expected between 11.2%-11.5%, compared to 12.4% last year.
Fiscal 2024 capital expenditures projected at $760 million, focused on new stores, distribution centers, and IT investments.
Sufficient liquidity projected to fund operations, investments, debt repayments, and shareholder returns for at least the next 12 months.
Latest events from Ross Stores
- Record sales, margin gains, and robust outlook drive increased shareholder returns for 2026.ROST
Q4 20263 Mar 2026 - Q2 2024 sales and EPS rose sharply, prompting a higher full-year outlook amid ongoing uncertainty.ROST
Q2 202523 Jan 2026 - Q3 sales up 10%, EPS $1.58, and FY25 guidance raised as tariff impacts subside.ROST
Q3 202610 Dec 2025 - Net earnings hit $2.1B in 2024; 2025 outlook is cautious amid macro headwinds.ROST
Q4 202510 Dec 2025 - Proxy covers director elections, say-on-pay, CEO transition, and strong ESG and governance.ROST
Proxy Filing1 Dec 2025 - Annual meeting to address director elections, executive pay, and auditor ratification.ROST
Proxy Filing1 Dec 2025 - Q2 sales up 5% to $5.5B, EPS $1.56, with cautious full-year outlook amid tariff headwinds.ROST
Q2 202623 Nov 2025 - Q1 sales rose 2.6% with stable margins; outlook cautious amid tariff and macro uncertainty.ROST
Q1 202618 Nov 2025